Leaders

Dr. Erin Saricilar
Co-founder and Chief Medical Officer

Natasha Bian
Co-founder and CEO
Investment Team
challenges
Glucose is the foundation of metabolic health, but current devices for measuring blood glucose aren't real-time, are invasive and aren't suited to mass-market use.
solution
Xoma have developed the world’s first non-invasive clinically validated device for measuring blood glucose levels in real time. This device has strong clinical evidence to support its efficacy. This will be applicable to both diabetic patients, and consumers seeking to better understand their metabolic health.
You might also like
For founders
Building for the systems that matter? Pitch us.
We back founders turning breakthrough science into category-defining companies.
For investors
Invest with Main Sequence
Access Australia's deep tech frontier alongside us.







